SCHEMBL19706253

SCHEMBL19706253

O=P(O)(O)OC[C@@H]1CC[C@H](n2cnc3c(/C=C/c4ccccc4)ncnc32)O1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RY12 Q9H244 7/20 0.50
▸ DNPH1 O43598 6/20 0.46
▸ IMPDH2 P12268 1/20 0.45
▸ TAS1R3 Q7RTX0 2/20 0.41
▸ TAS1R1 Q7RTX1 2/20 0.41
▸ PRKAB2 O43741 1/20 0.41
▸ TRPM2 O94759 1/20 0.41
▸ LDHA P00338 1/20 0.41
▸ ADRB2 P07550 1/20 0.41
▸ FBP1 P09467 1/20 0.41
▸ SRC P12931 1/20 0.41
▸ ADORA1 P30542 1/20 0.41
▸ P2RY2 P41231 1/20 0.41
▸ P2RY1 P47900 1/20 0.41
▸ PRKAG1 P54619 1/20 0.41
▸ PRKAA2 P54646 1/20 0.41
▸ PDE4D Q08499 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ PRKAA1 Q13131 1/20 0.41
▸ PDE3A Q14432 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19699229 0.85 POLB (0.56) P2RY12DNPH1IMPDH2P2RY1
SCHEMBL12566824 0.85 BCHE (0.42) P2RY12BCHE
SCHEMBL19706255 0.83 P2RY12 (0.40) P2RY12DNPH1IMPDH2
SCHEMBL4745859 0.81 DNPH1 (0.48) DNPH1TAS1R3TAS1R1PRKAB2TRPM2
SCHEMBL17363659 0.80 DNPH1 (0.71) P2RY12DNPH1IMPDH2TAS1R3TAS1R1
SCHEMBL16871695 0.80 DNPH1 (0.71) P2RY12DNPH1IMPDH2TAS1R3TAS1R1
SCHEMBL17363660 0.80 DNPH1 (0.71) P2RY12DNPH1IMPDH2TAS1R3TAS1R1
SCHEMBL20324734 0.80 P2RY1 (0.47) DNPH1TAS1R3TAS1R1PRKAB2TRPM2
SCHEMBL20225051 0.80 P2RY1 (0.62) DNPH1TAS1R3TAS1R1PRKAB2TRPM2
SCHEMBL20959779 0.80 P2RY1 (0.62) DNPH1TAS1R3TAS1R1PRKAB2TRPM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10342819-B2 Oligonucleotide having non-natural nucleotide at 5′-terminal thereof KYOWA HAKKO KIRIN CO., LTD. (JP) 2019-07-09 — — US disclosed
US-20170354673-A1 OLIGONUCLEOTIDE HAVING NON-NATURAL NUCLEOTIDE AT 5'-TERMINAL THEREOF KYOWA HAKKO KIRIN CO., LTD. (JP) 2017-12-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10342819-B2 Oligonucleotide having non-natural nucleotide at 5′-terminal thereof RNGTT, UPF1, NSUN3 P2RY12 3118/4885DNPH1 2051/4885IMPDH2 1254/4885
US-20170354673-A1 OLIGONUCLEOTIDE HAVING NON-NATURAL NUCLEOTIDE AT 5'-TERMINAL THEREOF RNGTT, UPF1, NSUN3 P2RY12 3171/4885DNPH1 2035/4885IMPDH2 1249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback